Is this ‘de-extinction’ project actually onto something?

Colossal, a biotech startup backed by major VCs and intelligence agencies, is shifting its de-extinction narrative to emphasize practical conservation technologies with immediate real-world applications, including reproductive techniques and genetic biobanking for endangered species preservation. While the company's previous projects faced criticism for misleading claims and potentially diverting resources from existing conservation efforts, its latest work on reproductive harvesting technology and open-source genetic repositories demonstrates tangible value that could benefit broader conservation strategies. For IT leaders, this represents an emerging intersection of synthetic biology, data management, and biotech infrastructure that will require new capabilities in genomic data handling, security, and collaborative data sharing platforms.